The Gain Train

Protocol for Researching The Gain Train:

LGD-4033 – For research use only, 1 filled oral syringe daily. LGD-4033 can be researched for up to 8 weeks. After completion of a cycle, there should be an 8-week break before resuming research.

S23 – For research use only, 1 filled oral syringe daily. S23 can be researched for up to 8 weeks.

PCT – After completion of the cycle, Nolva or Clomid should be used for PCT, at 1 oral syringe per day for 30 days.

S23

S-23 is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc as a potential male hormonal contraceptive. It binds to the androgen receptor more strongly than older drugs such as andarine with a Ki of 1.7 nM, and in animal studies it showed both a good ratio of anabolic to androgenic effects, and dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation of treatment.

LGD-4033

According to a clinical trial conducted at the Boston Medical Center’s Section of Endocrinology, Ligandrol can help improve lean body mass and muscle strength.

Another study conducted in January 2013 found that Ligandrol can help increase lean muscle mass, and was generally well tolerated by test subjects.

Get the Gain Train Stack here